A case study in flux balance analysis: Lysine, a cephamycin C precursor, can also increase clavulanic acid production

Biochemical Engineering Journal

Volumn 112, Issue , 2016, Pages 42-53

  Cavallieri, André Pastrelo ^a   Baptista, Amanda Salvador ^a   Leite, Carla Andréa ^a   Araujo, Maria Lucia Gonsales da Costa ^a  

^a SÃO PAULO STATE UNIVERSITY UNESP   (Brazil)

Author keywords

Antibiotic; Filamentous bacteria; Flux balance analysis; Growth kinetics; Lysine; Physiology

Indexed keywords

ANTIBIOTICS; BACTERIA; BIOCHEMISTRY; BIOSYNTHESIS; CARBOXYLIC ACIDS; GROWTH KINETICS; METABOLISM; METABOLITES; PHYSIOLOGY;

BIOACTIVE COMPOUNDS; COMPLEX RELATIONSHIPS; FILAMENTOUS BACTERIA; FLUX BALANCE ANALYSIS; LYSINE; METABOLIC FLUX ANALYSIS; SECONDARY METABOLITES; STREPTOMYCES CLAVULIGERUS;

AMINO ACIDS;

CEPHAMYCIN C; CLAVULANIC ACID; LYSINE; MALTOSE;

ARTICLE; DRUG METABOLISM; DRUG SYNTHESIS; FLUX BALANCE ANALYSIS; MATHEMATICAL MODEL; METABOLIC FLUX ANALYSIS; NONHUMAN; PRECURSOR; PRIORITY JOURNAL; STREPTOMYCES CLAVULIGERUS;

EID: 84962911719     PISSN: 1369703X     EISSN: 1873295X     Source Type: Journal    
DOI: 10.1016/j.bej.2016.03.012     Document Type: Article

References (45)

1. Dauner M., Sauer U. Stoichiometric growth model for riboflavin-producing Bacillus subtilis. Biotechnol. Bioeng. 2001, 76:132-143.
2. Bailey J.E. Mathematical modeling and analysis in biochemical engineering: past accomplishments and future opportunities. Biotechnol. Progr. 1998, 14:8-20.
3. Tee T.W., Chowdhury A., Maranas C.D., Shanks J.V. Systems metabolic engineering design: fatty acid production as an emerging case study. Biotechnol. Bioeng. 2014, 111:849-857.
4. Stephanopoulos G., Aristidou A.A., Nielsen J. Metabolic Engineering: Principles and Methodologies 1998, Academic press, San Diego. 1st ed.
5. Gombert A.K., Nielsen J. Mathematical modelling of metabolism. Curr. Opin. Biotechnol. 2000, 11:180-186.
6. Liras P. Biosynthesis and molecular genetics of cephamycins. A. Van. Leeuw. J. Microb. 1999, 75:109-124.
7. Domingues L.C., Teodoro J.C., Hokka C.O., Badino A.C., Araujo M.L.G. Optimisation of the glycerol-to-ornithine molar ratio in the feed medium for the continuous production of clavulanic acid by Streptomyces clavuligerus. Biochem. Eng. J. 2010, 53:7-11.
8. Leite C.A., Cavallieri A.P., Araujo M.L. Enhancing effect of lysine combined with other compounds on cephamycin C production in Streptomyces clavuligerus. BMC Microbiol. 2013, 13:296-307.
9. Álvarez-Álvarez R., Rodríguez-García A., Santamarta I., Pérez-Redondo R., Prieto-Domínguez A., Martínez-Burgo Y., Liras P. Transcriptomic analysis of Streptomyces clavuligerus (ccaR: tsr: effects of the cephamycin C-clavulanic acid cluster regulator CcaR on global regulation. Microbial. Biotechnol. 2014, 7:221-231.
10. de la Fuente A., Lorenzana L.M., Martín J.F., Liras P. Mutants of Streptomyces clavuligerus with disruptions in different genes for clavulanic acid biosynthesis produce large amounts of holomycin: possible cross-regulation of two unrelated secondary metabolic pathways. J. Bacterial. 2002, 184:6559-6565.
11. Bushell M.E., Kirk S., Zhao H.J., Avignone-Rossa C.A. Manipulation of the physiology of clavulanic acid biosynthesis with the aid of metabolic flux analysis. Enzyme Microb. Technol. 2006, 39:149-157.
12. Medema M.H., Alam M.T., Heijne W.H., van den Berg M.A., Müller U., Trefzer A., Bovenberg R.A.L., Breitling R., Takano E. Genome-wide gene expression changes in an industrial clavulanic acid overproduction strain of Streptomyces clavuligerus. Microbial. Biotechnol. 2011, 4:300-305.
13. Sánchez C., Quintero J.C., Ochoa S. Flux balance analysis in the production of clavulanic acid by Streptomyces clavuligerus. Biotechnol. Progr. 2015, 1:1-11.
14. Kazuyuki S. Toward systematic metabolic engineering based on the analysis of metabolic regulation by the integration of different levels of information. Biochem. Eng. J. 2009, 46:235-251.
15. Schuetz R., Kuepfer L., Sauer U. Systematic evaluation of objective functions for predicting intracellular fluxes in Escherichia coli. Mol. Syst. Biol. 2007, 3:119-134.
16. Feist A.M., Palsson B.O. The biomass objective function. Curr. Opin. Microbial. 2010, 13:344-349.
17. Knorr A.L., Jain R., Srivastava R. Bayesian-based selection of metabolic objective functions. Bioinformatics 2007, 23:351-357.
18. Bahadur M.B., Tsuboi R., Kurata H. Complementary elementary modes for fast and efficient analysis of metabolic networks. Biochem. Eng. J. 2014, 90:121-130.
19. Butterworth D. Clavulanic acid: properties biosynthesis, and fermentation. Biotechnology of Industrial Antibiotics 1984, 3-31. Marcel Dekker, New York. E.J. Vandamme (Ed.).
20. Sánchez L., Brana A.F. Cell density influences antibiotic biosynthesis in Streptomyces clavuligerus. Microbiology 1996, 142:1209-1220.
21. Liras P., Martín J.F. Assay Methods for Detection and Quantification of Antimicrobial Metabolites Produced by Streptomyces clavuligerus 2005, 149-164. Humana Press, New York. J.L. Barredo (Ed.).
22. Foulstone M., Reading C. Assay of Amoxicillin and Clavulanic Acid the Components of Augmentin, in biological fluids with high-performance liquid chromatography. Antimicrob. Agents Ch. 22 1982, 753-762.
23. Hartree E.F. Determination of protein: a modification of the Lowry method that gives a linear photometric response. Anal. Biochem. 1972, 48:422-427.
24. Marquardt D.W. An algorithm for least-squares estimation of nonlinear parameters. J. Soc. Ind. Appl. Math. 1963, 11:431-441.
25. Chan M., Sim T.S. Malate synthase from Streptomyces clavuligerus NRRL3585: cloning, molecular characterization and its control by acetate. Microbiol. 1998, 144:3229-3237.
26. Seng S.B., Loke P., Tiow-Suan S. Cloning heterologous expression and purification of an isocitrate lyase from Streptomyces clavuligerus NRRL 3585. BBA-Gene Struct. Expr. 2001, 1522:112-117.
27. Nelson D.L., Lehninger A.L., Cox M.M. Lehninger Principles of Biochemistry 2008, Macmillan, New York. 5th ed.
28. Madduri K., Stuttard C., Vining L.C. Lysine catabolism in Streptomyces spp. is primarily through cadaverine: beta-lactam producers also make alpha-aminoadipate. J. Bacteriol. 1989, 171:299-302.
29. Antonio T., Bellão C., Corrêa T., Cavallieri A.P., Badino A.C., Araujo M.L.G.D.C. Evaluation of different media for the production of cephalosporins by Streptomyces clavuligerus ATCC 27064. Braz. Arch. Biol. Technol. 2012, 55:819-825.
30. Shahab N., Flett F., Oliver S.G., Butler P.R. Growth rate control of protein and nucleic acid content in Streptomyces coelicolor A3 (2) and Escherichia coli B/r. Microbiology 1996, 142:1927-1935.
31. Karandikar A., Sharples G.P., Hobbs G. Differentiation of Streptomyces coelicolor A3 (2) under nitrate-limited conditions. Microbiology 1997, 143:3581-3590.
32. Rocha I., Maia P., Evangelista P., Vilaça P., Soares S., Pinto J.P., Nielsen J., Patil K., Ferreira E.C., Rocha M. OptFlux: an open-source software platform for in silico metabolic engineering. BMC Syst. Biol. 2010, 4:45-57.
33. Demain A.L., Vaishnav P. Involvement of nitrogen-containing compounds in β-lactam biosynthesis and its control. Crit. Rev. Biotechnol. 2006, 26:67-82.
34. Fredrickson A.G., Megee R.D., Tsuchiya H.M. Mathematical Models for Fermentation Processes 1970, 419-465. Academic Press, New York. D. Perlman (Ed.).
35. Wentzel A., Bruheim P., Øverby A., Jakobsen Ø.M., Sletta H., Omara W.A., Hodgson D.A., Ellingsen T.E. Optimized submerged batch fermentation strategy for systems scale studies of metabolic switching in Streptomyces coelicolor A3 (2). BMC Syst. Biol. 2012, 6:59-75.
36. Aharonowitz Y., Demain A.L. Carbon catabolite regulation of cephalosporin production in Streptomyces clavuligerus. Antimicrob. Agents Ch. 14 1978, 159-164.
37. James P.D.A., Edwards C., Dawson M. The effects of temperature, pH and growth rate on secondary metabolism in Streptomyces thermoviolaceus grown in a chemostat. J. Gen. Microbiol. 1991, 137:1715-1720.
38. Singh M., Chaturvedi R. Evaluation of nutrient uptake and physical parameters on cell biomass growth and production of spilanthol in suspension cultures of Spilanthes acmella Murr. Bioprocess Biosyst. Eng. 2012, 35:943-951.
39. Goel A., Ferrance J., Jeong J., Ataai M.M. Analysis of metabolic fluxes in batch and continuous cultures of Bacillus subtilis. Biotechnol. Bioeng. 1993, 42:686-696.
40. Omstead D.R., Hunt G.H., Buckland B.C. Commercial production of cephamycin antibiotics. Comprehensive Biotechnology: the Principles, Applications and Regulations in Industry, Agriculture and Medicine 1985, 187-210. Pergamon Press, Oxford. M. Moo-Young (Ed.).
41. Zakrzewski P., Medema M.H., Gevorgyan A., Kierzek A.M., Breitling R., Takano E. MultiMetEval: comparative and multi-objective analysis of genome-scale metabolic models. PLoS One 2012, 7:1-9.
42. Van Gulik W.M., De Laat W.T.A.M., Vinke J.L., Heijnen J.J. Application of metabolic flux analysis for the identification of metabolic bottlenecks in the biosynthesis of penicillin-G. Biotechnol. Bioeng. 2000, 68:602-618.
43. Bellão C., Antonio T., Araujo M.L.G.C., Badino A.C. Production of clavulanic acid and cephamycin C by Streptomyces clavuligerus under different fed-batch conditions. Braz. J. Chem. Eng. 2013, 30:257-266.
44. Leite C.A., Cavallieri A.P., Baptista A.S., Araujo M.L.G.C. Dissociation of cephamycin C and clavulanic acid biosynthesis by 1, 3-diaminopropane in Streptomyces clavuligerus. FEMS Microbiol. Lett. 2016, 363:fnv215.
45. Maranesi G.L., Baptista-Neto A., Hokka C.O., Badino A.C. Utilization of vegetable oil in the production of clavulanic acid by Streptomyces clavuligerus ATCC 27064. World J. Microb. Biot. 2005, 21:509-514.